Diagnosis and treatment of bronchial asthma

bronchial asthma is a chronic respiratory disease, usually manifested in repeated cases of asthma, air rush, chest depression or cough. Their morbidity may be related to genetic, environmental, allergies, etc. The diagnosis and treatment of bronchial asthma is described below:Diagnosis of bronchial asthmaThe diagnosis of bronchial asthma is based mainly on clinical symptoms, signs and associated ancillary examinations of the patient.Clinical symptoms:Repeated gasp, breath, chest and cough.Breathing takes the form of breathing in which a sonic boom can be heard, similar to whistling. When people are in a state of emergency, they can find it hard to breathe. When they are bored, they feel oppressed or overstretched. Cough may be dry or may be accompanied by cough.These symptoms are usually induced or aggravated by exposure to allergies, severe motion, respiratory infections, climate change, etc., and may become more visible at night and in the morning.3. Auxiliary inspection:bronchial stretch: Positive results suggest reversibility of the current and are an important aid to the diagnosis of asthma.bronchial bronchial stimulation test: Positive results suggest a high-reactive gas route, facilitating asthma diagnosis.Pneumatic peak (PEF): average day and night variability (at least 7 consecutive days) > 10%, or PEF weekly variability > 20%, may serve as one of the diagnostic bases for asthma.Lung functional examination: Indicators such as a one-second air flux and a ratio of strong pulmonary activity can reflect the severity of air-traffic congestion and are important tools for assessing asthma.In addition, patients with unusual symptoms may be treated on asthma and observed after coughing or chest suffocation due to other diseases, if they are shown to be repeated coughing or chest suffocation only and have objective proof of a restricted variable air flow.II. bronchial asthma treatmentThe aim of bronchial asthma treatment is to control symptoms, reduce onset, improve quality of life and avoid complications and long-term damage. Treatment programmes should be tailored to the patient ‘ s condition and individualized characteristics, and the effectiveness of treatment should be evaluated on a regular basis.1. Drug treatment:Drug control: used for long-term control of asthma symptoms to reduce frequency and severity of onset. These include inhaled sugar cortex hormones (e.g., Boudinaid, fluidekason, etc.), long-acting beta2 receptor agonists (e.g., salmetro, etc.) and white tritrile regulators (e.g., sodium monuste, etc.).Anti-pharmaceuticals: Rapidly mitigating bronchial convulsions and symptoms during acute onset. These include short-acting β2 receptor agonists (e.g. salbutamol), short-acting anticholines (e.g. ammonium isopropyl bromide) and whole-body sugar cortex hormones (used during severe onset).2. Non-pharmacological treatment:Avoiding induction factors: Excludes or reduces induction factors for exposure to asthma, such as indoor and outdoor allergies, cold air, sensitive food, etc. Maintain good indoor air quality and avoid smoking.Improving living habits: Maintaining healthy living habits, such as exercise, proper diet, adequate sleep, etc., helps to increase physical immunity and reduce the frequency and severity of asthma attacks.3. Specific immunotherapy:Specific immunotherapy (i.e., de-sensitization treatment) may be considered for people with identified asthma in the allergy, to reduce asthma symptoms and to reduce the high aerobic reaction through subcutaneous injections or the use of commonly inhaled allergies under the tongue.4. Urgent:In cases of acute asthma, the patient should be given rapid palliative care and treated as soon as possible. For severe asthma attacks, emergency medical treatment and mechanical ventilation support may be required.In the light of the above, the diagnosis and treatment of bronchial asthma requires a combination of clinical symptoms, signs and the results of the relevant secondary examinations. Treatment programmes should be tailored to the patient ‘ s condition and individualization, and periodic follow-up visits should be made to assess the efficacy of the treatment in order to adjust it. At the same time, patients should actively cooperate with doctors ‘ recommendations for treatment, improve living habits and avoid induced factors to reduce asthma.